Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Archives of Biochemistry and Biophysics|December 1, 1996
Interaction of a dimeric mitochondrial precursor with phospholipid vesicles: direct association of each subunit with the membrane is required for loss of functionalityA Berezov, A Iriarte, M Martinez-CarrionThe Journal of Biological Chemistry|September 2, 1994
Binding to phospholipid vesicles impairs substrate-mediated conformational changes of the precursor to mitochondrial aspartate aminotransferaseA Berezov, A Iriarte, M Martinez-CarrionJournal of Medicinal Chemistry|July 27, 2001
Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysisA Berezov, H T Zhang, M I Greene, et al.DNA and Cell Biology|December 14, 1999
The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expressionJ Roland, A Berezov, M I Greene, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|July 31, 2003
Antibody like peptidomimetics as large scale immunodetection probesR Murali, Q Liu, X Cheng, et al.Oncogene|June 21, 2006
AHNP-streptavidin: a tetrameric bacterially produced antibody surrogate fusion protein against p185her2/neuK Masuda, M Richter, X Song, et al.Oncogene|September 6, 2011
Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivinA Berezov, Z Cai, J A Freudenberg, et al.Oncogene|June 13, 2012
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14J-M Huang, I Nagatomo, E Suzuki, et al.Nature Biotechnology|February 5, 2000
Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivoB W Park, H T Zhang, C Wu, et al.Oncogene|September 23, 2014
Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastomaS N Brun, S L Markant, L A Esparza, et al.Pageof 1